Over the last 7 days, the Life Sciences industry has dropped 5.9%, driven by a pullback from Thermo Fisher Scientific of 5.8%. Overall the industry is down 5.5% in 12 months. Earnings are forecast to grow by 16% annually.
Has the U.S. Life Sciences Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 19 Apr 2024 | US$682.0b | US$142.0b | US$12.8b | 41x | 53.3x | 4.8x |
Sun, 17 Mar 2024 | US$742.0b | US$142.1b | US$12.8b | 43.9x | 57.8x | 5.2x |
Tue, 13 Feb 2024 | US$709.9b | US$141.9b | US$12.7b | 39.2x | 55.8x | 5x |
Thu, 11 Jan 2024 | US$692.8b | US$153.9b | US$14.2b | 36.6x | 48.9x | 4.5x |
Sat, 09 Dec 2023 | US$648.8b | US$153.7b | US$14.0b | 35.2x | 46.3x | 4.2x |
Mon, 06 Nov 2023 | US$595.2b | US$153.9b | US$11.0b | 31.5x | 54x | 3.9x |
Wed, 04 Oct 2023 | US$640.4b | US$154.6b | US$11.2b | 32.3x | 57.2x | 4.1x |
Fri, 01 Sep 2023 | US$733.5b | US$154.6b | US$11.2b | 32.9x | 65.4x | 4.7x |
Sun, 30 Jul 2023 | US$734.3b | US$154.7b | US$11.6b | 31.5x | 63.2x | 4.7x |
Tue, 27 Jun 2023 | US$687.9b | US$152.4b | US$12.5b | 29.3x | 55x | 4.5x |
Thu, 25 May 2023 | US$671.4b | US$152.2b | US$12.5b | 27.8x | 53.7x | 4.4x |
Sat, 22 Apr 2023 | US$728.5b | US$154.6b | US$10.8b | 29.9x | 67.4x | 4.7x |
Mon, 20 Mar 2023 | US$700.9b | US$154.5b | US$10.8b | 27.3x | 64.8x | 4.5x |
Wed, 15 Feb 2023 | US$749.4b | US$154.2b | US$8.6b | 32.4x | 87.2x | 4.9x |
Fri, 13 Jan 2023 | US$756.5b | US$155.3b | US$8.5b | 30.4x | 88.7x | 4.9x |
Sun, 11 Dec 2022 | US$761.9b | US$155.1b | US$8.8b | 28.4x | 86.8x | 4.9x |
Tue, 08 Nov 2022 | US$707.8b | US$154.9b | US$9.1b | 26.4x | 78.1x | 4.6x |
Thu, 06 Oct 2022 | US$758.4b | US$152.5b | US$17.0b | 25x | 44.6x | 5x |
Sat, 03 Sep 2022 | US$753.3b | US$152.3b | US$17.3b | 28.7x | 43.5x | 4.9x |
Mon, 01 Aug 2022 | US$835.9b | US$151.6b | US$18.2b | 34.2x | 45.8x | 5.5x |
Wed, 29 Jun 2022 | US$727.9b | US$148.1b | US$20.1b | 30.3x | 36.2x | 4.9x |
Fri, 27 May 2022 | US$721.0b | US$148.0b | US$20.0b | 29.9x | 36x | 4.9x |
Sun, 24 Apr 2022 | US$806.5b | US$147.3b | US$25.4b | 33.7x | 31.8x | 5.5x |
Tue, 22 Mar 2022 | US$866.3b | US$145.0b | US$25.3b | 36.8x | 34.2x | 6x |
Thu, 17 Feb 2022 | US$849.5b | US$144.2b | US$24.9b | 38.3x | 34.1x | 5.9x |
Sat, 15 Jan 2022 | US$878.2b | US$138.0b | US$27.3b | 39.9x | 32.1x | 6.4x |
Mon, 13 Dec 2021 | US$959.0b | US$138.0b | US$27.3b | 43.1x | 35.1x | 6.9x |
Wed, 10 Nov 2021 | US$965.1b | US$137.6b | US$27.2b | 47x | 35.5x | 7x |
Fri, 08 Oct 2021 | US$713.9b | US$105.9b | US$18.6b | 47x | 38.4x | 6.7x |
Sun, 05 Sep 2021 | US$754.2b | US$105.8b | US$18.7b | 52x | 40.4x | 7.1x |
Tue, 03 Aug 2021 | US$708.7b | US$105.8b | US$18.7b | 45.1x | 38x | 6.7x |
Fri, 07 May 2021 | US$604.0b | US$97.3b | US$17.5b | 41.2x | 34.6x | 6.2x |
34.6x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | -3.65% | |
Healthcare | -2.54% | |
Life Sciences | -5.94% | |
Clinical Research and Equipment | -5.94% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
SYNH Syneos Health | US$42.98 | 0.6% +US$24.9m | -8.8% | PE62.6x | |
LFCR Lifecore Biomedical | US$6.32 | 2.4% +US$4.4m | 60.7% | PS1.9x | |
CSBR Champions Oncology | US$5.07 | 2.9% +US$1.9m | -1.5% | PS1.4x | |
SEER Seer | US$1.75 | 1.2% +US$1.3m | -52.4% | PS6.8x | |
MIRO Miromatrix Medical | US$3.39 | 1.2% +US$1.1m | 18.5% | PS97x |